RDW:NYSERedwire Corporation Analysis
Data as of 2026-04-28 - not real-time
$9.33
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Redwire (RDW) trades at $9.33, well below its consensus 12‑month target of $14.11, implying roughly a 51% upside. Technical indicators show a neutral stance: the 20‑day SMA (9.77) sits just above the 50‑day SMA (9.31) and the 200‑day SMA (9.43), the RSI is at 46.9 (neither overbought nor oversold), and the MACD histogram is negative, signaling short‑term bearish momentum. Volatility is extreme, with a 30‑day range exceeding 100% and a beta above 3, indicating the stock moves sharply with market swings. Fundamentals are weak – the company reports negative earnings, a -20 forward P/E, and a -67% profit margin, yet revenue grew 56% YoY and the price‑to‑sales ratio stands at 5.5, reflecting growth expectations. Recent material news adds a catalyst: an ESA award to develop a quantum‑secure satellite (QKDSat) and the opening of a UK office, expanding its international footprint and contract pipeline. Volume is increasing, supporting liquidity, but the lack of dividend and high debt‑to‑equity (≈11) raise concerns. Overall, the market appears to discount Redwire’s long‑term space‑infrastructure potential, creating a valuation gap that could be exploited if the company can translate its contract wins into cash‑flow positivity.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram suggests limited upside in the near term
- Current price sits just above the identified support level
- High short‑term volatility may erode gains
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- ESA quantum‑secure satellite contract provides a tangible revenue catalyst
- Undervalued relative to target price and strong upside potential
- Revenue growth of 56% indicates expanding market traction
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic position in the emerging space‑infrastructure ecosystem
- Growing government and commercial contract backlog
- Potential to improve margins as scale and technology maturity increase
Key Metrics & Analysis
Financial Health
Revenue Growth56.40%
Profit Margin-67.55%
P/E Ratio-20.3
ROE-41.75%
ROA-11.49%
Debt/Equity10.89
P/B Ratio1.7
Op. Cash Flow$-177331008
Free Cash Flow$-120076128
Industry P/E31.1
Technical Analysis
TrendNeutral
RSI46.9
Support$7.43
Resistance$12.30
MA 20$9.77
MA 50$9.31
MA 200$9.43
MACDBearish
VolumeIncreasing
Fear & Greed Index89.25
Valuation
Target Price$14.11
Upside/Downside51.24%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta3.14
Volatility104.44%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.